Characteristics of Patients with No 18F-FDG Uptake (PET0) and with Positive 18F-FDG Uptake (PET+)
| Patient characteristic | PET0 (n = 10) | PET+ (n = 8) |
| Age (y) | ||
| Median | 75 | 78 |
| IQR | 71–80 | 69–81 |
| Body mass index (kg/m2) | ||
| Median | 26.1 | 25.2 |
| IQR | 24.0–28.7 | 23.0–27.7 |
| Deciding factor for surgery | ||
| Size ≥ 55 mm | 8 | 2 |
| Growth/pain | 1 | 4 |
| Anxiety | 1 | 2 |
| Sex distribution | ||
| Male | 10 | 6 |
| Female | 0 | 2 |
| Cardiovascular events | 6 | 1 |
| Hypertension | 8 | 4 |
| Smoker | ||
| Current | 3 | 3 |
| Former | 5 | 4 |
| COPD | 5 | 4 |
| Diabetes | 1 | 0 |
| Hyperlipidemia | 6 | 4 |
| Statins | 8 | 4 |
| β-blocker | 5 | 2 |
| Calcium channel blocker | 3 | 2 |
| ACEI | 2 | 0 |
| NSAID | 0 | 2 |
IQR = interquartile range; COPD = chronic obstructive pulmonary disease; ACEI = angiotensin-converting enzyme inhibitor; NSAID = nonsteroidal antiinflammatory drug.